Barely Significant
← all excerpts

Serum hepcidin as a biomarker of treatment response in Gaucher disease.

Mol Genet Metab Rep · 2025 · PMC12495281 · PMID 41050549

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)
Serum IL-6 levels showed a trend toward reduction after treatment (pre-treatment 1.75 [1.02–2.23] pg/mL vs post-treatment 0.92 [0.26–2.36] pg/mL; P = 0.06 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.